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Muscle wasting that occurs during aging or from disease pathology presents with an
accumulation of lipid species termed ceroid or lipofuscin. This unique species of lipid
has been characterized in various cell types but its properties and organization in
skeletal muscle remains unclear. Using immunofluorescence and transmission electron
microscopy, we were able to visualize and characterize an atypical lipid storing organelle
in skeletal muscle. White myofibers contain two organelles at each pole of the myonuclei
and red myofibers contain many of these structures in and around the perinuclear space.
These organelles contain markers for late endosomes, are morphologically similar to
multivesicular bodies, store lipid, and hypertrophy in aged muscle and a model of muscle
wasting with an accumulation of large amounts of lipofuscin. Rapamycin treatment
reduces the multivesicular body hypertrophy, restores late endosomal protein markers,
and also increases the number and intensity of lipofuscin deposits. Together, these data
demonstrate for the first time a perinuclear organelle in skeletal muscle that hypertrophies
in muscle wasting phenotypes and is involved in endocytic lipid storage.
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INTRODUCTION
The late endosome, or multivesicular body (MVB), was originally characterized as a unique
endosomal compartment in the 1950s (Palade, 1955; Sotelo and Porter, 1959). The membrane
bound organelle contains many intraluminal vesicles (ILVs) that encapsulate cargo destined
for degradation via the lysosome. These ILVs are the result of the endosomal sorting complex
required for transport (ESCRT) protein machinery. This protein complex responds to signals like
ubiquitination and packages cytoplasmic proteins into the ILVs. These ILVs are also enriched in
specialized membrane proteins and unique lipid species (Hirst et al., 1998; Matsuo et al., 2004).
Uponmaturation, theMVB fuses and releases the ILVs into the acidic lumen of the lysosome, which
are then degraded by the numerous hydrolases present. This unidirectional process makes theMVB
the last sorting step for cargo in the endocytic pathway (Piper and Katzmann, 2007; Hanson and
Cashikar, 2012). Cross talk with the autophagic pathway has also been demonstrated as MVBs
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can fuse with autophagasomes, creating hybrid organelles called
amphisomes (Filimonenko et al., 2007). Recent findings have also
demonstrated that the cargo in the ILVs can be released into the
interstitial space as structures termed exosomes, which arise by
the fusion of the MVBs with the plasma membrane (Raposo and
Stoorvogel, 2013).
Skeletal muscle is one of the three types of muscle, and
functions to support the skeleton and facilitate movement
by connecting to the bones via tendons. Skeletal muscle has
a unique architecture to enable its function of contraction
and relaxation. The individual muscle cell, or myofiber, is an
elongated, multinucleated, post-mitotic cell resulting from the
fusion of hundreds of muscle precursor cells. Each myofiber
contains many contractile units called sarcomeres, which contain
the actin filaments and myosin motors that mechanically
undergo contraction and relaxation. Individual myofibers exist
in larger bundles called a fascicle that encompasses roughly
100 myofibers contained within a sheath of connective tissue
called the epimysium. Many fascicles then make up the larger
architecture of the muscle, all contained within a second sheath
of connective tissue called the perimysium. Innervation of the
muscle combined with calcium flux from the sarcoplasmic
reticulum allows all the individual myofibers to contract in
unison to produce force (Au, 2004; Braun and Gautel, 2011).
Skeletal muscle can be classified into multiple fiber subtypes
based upon expression of various myosin isoforms, rates of
contraction, and metabolic fuels (glucose and fatty acids) used
as energy sources. In general, the two major fiber types are
red, oxidative, type I fibers and white, glycolytic, type II
fibers. Red muscle is high in myoglobin and mitochondria,
primarily undergoes oxidative metabolism, and is resistant
to fatigue. White muscle is relatively low in myoglobin
and mitochondria, primarily undergoes glycolytic metabolism,
and is susceptible to fatigue. Numerous research articles
and reviews have detailed many differences between the
fiber types, including differential sensitivity to extracellular
signals and specificity for muscle wasting in certain diseases
(Schiaffino and Reggiani, 2011; Wang and Pessin, 2013).
Skeletal muscle wasting is generally defined by loss of muscle
mass and strength and can be caused by a multitude
of factors from diseases, drugs, denervation, disuse, and
aging.
Much work has been done examining the loss of muscle mass
and function in relation to aging, a physiologic process termed
sarcopenia. Although it is unclear why aged muscle wastes, it
has been clearly demonstrated that this is part of the normal
progression of aging. Research has shown that satellite cell
number and activation decreases, skeletal muscle regeneration
rates decrease, apoptosis increases, and physiological processes
like protein synthesis and autophagic and lysosomal degradation
become compromised in aged muscle (Dirks and Leeuwenburgh,
2002; Marzetti and Leeuwenburgh, 2006; Shefer et al., 2006, 2010;
Wohlgemuth et al., 2010; Chakkalakal et al., 2012). Although
these studies are important in relation to investigating aged
skeletal muscle biology, they do not address whether these
processes are the cause or response to the development of
sarcopenia.
Interestingly, other forms of muscle wasting caused by specific
diseases also present with many of the same cellular phenotypes
seen in aging. For example, Pompe’s Disease is a glycogen storage
disorder where large amounts of glycogen accumulate specifically
in skeletal and cardiac muscle. This is due to a mutation in alpha
acid glucosidase (GAA) which functions to break down glycogen
into glucose in the lysosome. The adult onset phenotype presents
with severe peripheral muscle wasting that is primarily reserved
to white muscle.
The accumulation of an inert lipid byproduct called lipofuscin
is common to both sarcopenia and Pompe’s Disease and results
from reduced lysosomal degradation (Hütter et al., 2007; Feeney
et al., 2014). Metabolic byproducts build up and become oxidized
to create a material that contains fatty acids, proteins, sugars,
and metals that cannot be degraded or exocytosed (Brunk and
Terman, 2002; Terman and Brunk, 2004; Jung et al., 2007).
Lipofuscin has been well characterized to be a hallmark of aging
that accumulates in post-mitotic cells, primarily in perinuclear
pools (Nakae et al., 2004). Lipofuscin has also been implicated in
the pathologies ofmany diseases such as Alzheimer’s, Parkinson’s,
amyotrophic lateral sclerosis, and lysosomal storage disorders
(D’Andrea et al., 2002; Hesselink et al., 2003; Zheng et al., 2010;
Bandyopadhyay et al., 2014). Despite many studies examining
lipofuscin, many basic questions remain as to how it accumulates,
whether it is pathogenic, and whether it can be cleared.
Very few drugs or therapies have been shown to be effective
to combat the loss of muscle mass and strength seen in
sarcopenia and Pompe’s Disease. Rapamycin is a naturally
occurring bacterial byproduct that has been shown to be an
inhibitor of the protein kinase, target of rapamycin (TOR; Ballou
and Lin, 2008). In mammalian cells, the mTOR complex 1
(mTORC1) senses nutrient availability, stress, growth factors,
oxygen abundance, and DNA damage, and controls downstream
processes like protein synthesis, autophagy, energy metabolism,
lipid biosynthesis, and lysosome biogenesis (Laplante and
Sabatini, 2009). Through mechanisms not completely defined,
rapamycin has been shown to promote longevity in a variety
of species. Rapamycin modulates skeletal muscle mass as
well as specific metabolic functions, including glucose and
lipid utilization. However, its effect on sarcopenia is still not
conclusive, with some research suggesting the effect of rapamycin
on the loss of muscle mass and strength is minimal (Sipula
et al., 2006; Ballou and Lin, 2008; Neff et al., 2013; Zhang et al.,
2014). Nonetheless, rapamycin has a beneficial effect on Pompe’s
Disease by promoting clearance of the excess glycogen (Ashe
et al., 2010).
In this study, we have identified a perinuclear MVB-like
endocytic compartment that functions to sequester lipofuscin.
These unusual MVBs store lipofuscin but have a fiber type-
specific localization in different myofibers. In aged and Pompe
skeletal muscle, we show that these compartments specifically
enlarge as compared to other peripheral compartments and that
they accumulate lipofuscin. Rapamycin treatment can reverse
the hypertrophy of this compartment seen in sarcopenic muscle.
To our knowledge this is the first study showing that lipofuscin
is contained within a perinuclear multivesicular body like
compartment in a fiber type specific manner.
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METHODS
Animals
All animal experiments received ethical approval and were
performed in agreement with the Albert Einstein College of
Medicine Institutional Animal Care and Use Committee (2013-
1010). Young 2 month old C57Bl/6J mice were obtained from
Jackson Laboratories. Aged C57Bl/6J mice (∼24 months) were
obtained from the National Institute of Aging. 2 month old GAA-
deficient Pompe mice (6neo/6neo) on the C57Bl/6J background,
as described by Raben et al. (1998), were provided by Dr. Steven
Walkley (Albert Einstein College ofMedicine). Mice were housed
in a facility equipped with a 12 h light/dark cycle with free access
to food and water and were fed a normal chow diet (Research
Diets).
Single Myofiber Isolation
Mice were sacrificed and the extensor digitorum longus (EDL)
and soleus muscles were dissected from the proximal to
distal tendon. The muscles were then digested in 0.2% type I
collagenase (Sigma, St. Louis MO, USA) in a 37◦C water bath
with gentle agitation for 60–90min. Individual myofibers were
harvested by pipetting media over the muscle until the fibers
dissociated. Viable fibers were assessed as single, non-clumped
myofibers, elongated and not contracted, and intact without
any apparent cuts, bends, or wounds. The EDL muscle digests
faster and separation of the myofibers is easier and the yield of
viable myofibers is ∼80–90%. The soleus takes longer to digest
and the red myofibers are more easily torn and destroyed. A
good digestion may yield about half the fibers viable. These
viable fibers were then transferred into Dulbecco’sModified Eagle
Media (Fisher Scientific, Pittsburg, PA, USA) until the start of the
respective assay.
Immunofluorescence
Individual myofibers were isolated as described above and
then transferred to a 4% paraformaldehyde solution (Electron
Microscopy Sciences, Hatfield, PA, USA) and fixed at 37◦C
for 30min followed by two washes in PBS. The fixed fibers
were transferred to a blocking/permeabilization buffer for 2 h
[10% horse serum (Fisher Scientific, Pittsburg, PA, USA), 0.1%
Triton X100, 10mg/ml bovine serum albumin in PBS]. Myofibers
were incubated in primary antibodies overnight at 4◦C with
gentle rocking. After repeated washings in PBS, the myofibers
were incubated in fluorescent secondary antibodies (Life
Technologies, Eugene OR, USA) for 2 h at room temperature
with gentle rocking. After repeated washes in PBS, the fibers
were mounted on a coverslip with anti-fade Dapi mounting
medium (Cell Signaling, Danvers MA, USA). The following
primary antibodies were used: Lamp1 (BD Pharmigen, San
Jose, CA, USA), M6PR (Abcam, Cambridge, MA, USA), LBPA
(Echelon Biosciences, Salt Lake City, UT, USA). Samples were
imaged using a Leica SP5 AOBS confocal microscope using a 63x
objective. Image analysis was completed using the Lecia LAS-AF
software and ImageJ. For each immunostaining sample, at least
20 fibers were analyzed and for each condition, at least three
muscles were examined from different mice.
Transmission Electron Microscopy
Mice were sacrificed and the EDL and soleus muscles were
dissected from the proximal to distal tendon. The muscles were
then finely cut lengthwise into ∼10 pieces with a razor and
fixed with 2.5% glutaraldehyde, 2% paraformaldehyde in 0.1M
sodium cacodylate buffer, postfixed with 1% osmium tetroxide
followed by 2% uranyl acetate, dehydrated through a graded
series of ethanol and embedded in LX112 resin (LADD Research
Industries, Burlington, VT, USA). Ultrathin sections were cut on
a Reichert Ultracut UCT, stained with uranyl acetate followed by
lead citrate and viewed on a JEOL 1200EX transmission electron
microscope at 80 kv.
Focused Ion Beam Scanning Electron
Microscopy (FIB/SEM)
Individual myofibers from the EDL were harvested and fixed in
glutaraldehyde as described above. Staining and Durcupan ACM
resin embedding (EMS) was performed as described (Deerinck
et al., 2010). The sample block was then mounted on a SEM
sample holder using double sided carbon tape (EMS, Hatfield,
PA). Colloidal silver paint (EMS) was used to electrically ground
the exposed edges of the tissue block and the entire surface
of the specimen was then sputter coated with a thin layer of
gold/palladium (Denton Desk V). The tissue was imaged using
back-scattered electron (BSE) mode in a FEI Helios Nanolab 650.
Images were recorded after each round of ion beammilling using
the SEM beam at 2 keV and 100 pA with a working distance of
4mm. Data acquisition occurred in an automated way using the
Auto Slice and View G3 software, with an XY pixel size of 11–
13 nm and Z step size of 25 nm, resulting in typical volumes of
41.5µm by 44µm by 24.5µm.
Processing of SEM Image Stacks
Raw SEM images were cropped, and aligned using the image
processing programs in IMOD (UC Boulder). In particular, the
stack of SEM images were aligned using IMOD’s xfalign and
Midas programs. Further image analysis utilized a polynomial
filter in Image J (NIH) to reduce an overall intensity gradient.
Finally, the images were binned to produce isotropic voxels in
the x, y, and z direction (26.5 nm) with Amira software (Visage
Imaging, Andover, MA).
Oil Red O and Lipofuscin
Immunofluorescence
Individual myofibers were harvested and fixed as described
above. Immunostaining, described above, was performed first,
followed by oil red O (ORO) staining (Koopman et al., 2001).
A 5mg/ml stock solution of ORO was made in 60% triethyl-
phosphate. Prior to use, a 37% working solution was made and
filtered twice or until the solution is completely clear. ORO was
added to the previously immunostained myofibers for 30min
at room temperature with gentle rocking. The fibers were then
washed numerous times with H2O until all leftover ORO was
removed and then the fibers were mounted as described above.
ORO can be visualized by immunofluorescence at 594 nm. For
lipofuscin imaging, myofibers were mounted and visualized at
488 and 594 nm directly after fixation without any staining.
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Rapamycin Studies
Male C57Bl/6j mice aged ∼24 and ∼2 months were treated with
rapamycin or vehicle. Rapamcyin was prepared as a 1mg/ml
stock in 10% PEG400/10% Tween80 in ethanol. Mice underwent
a daily intraperitoneal injection at a concentration of 4mg/kg of
body weight for 1 month. Mice were then sacrificed and samples
were harvested, processed, and imaged as described above.
Immunoblotting
Skeletal muscle extracts were homogenized in ice-cold lysis buffer
(50mM Tris, pH 7.5, 150mM NaCl, 1% Triton X-100, 1mM
EDTA, 1mM phenylmethylsulfonyl fluoride, 0.25% sodium
deoxycholate, 1mM NaF, 1mM Na3VO4, and 2mM Na4P2O7)
containing a protease inhibitor mixture (Roche Diagnostics,
Indianapolis, IN, USA). The resultant lysates were centrifuged at
16,000 × g for 10min at 4◦C, and protein concentrations were
quantified using the BCA (bicinchoninic acid) protein assays
(ThermoFisher, Grand Island, NY, USA). The protein samples
(30µg) were separated on a 4–12% gradient SDS-PAGE gel
and transferred to nitrocellulose membranes using a semidry
electroblotter (Owl Separation System, Portsmouth, NH, USA).
Membranes were immunoblotted with Lamp1 and GAPDH
antibodies (Abcam, Cambridge, MA, USA). Quantification
of all immunoblots was performed using NIH IMAGE
software.
Statistical Analysis
Two tailed unpaired student’s t-test was used to evaluate
statistical significance in all quantitation analyses. Data are
presented as a standard deviation of the mean and p < 0.5 (∗)
was considered significant.
RESULTS
Skeletal Muscle has a Unique Perinuclear
Organelle
White glycolytic [extensor digitorum longus (EDL)] and
red oxidative (soleus) muscles were examined by confocal
microscopy. Initially, analyses of fiber type specificity used
myosin heavy chain markers to distinguish between white and
red myofibers; however, Lamp1 immunofluorescence indicated
the presence of Lamp1 positive structures at the poles of the
myonuclei in 2 month-old EDL muscle fibers (Figure 1A).
Although the pattern of the Lamp1 staining was more dispersed
in soleus muscle fibers it remained clustered around the
myonuclei (Figure 1B). After confirmation that EDL myofibers
always had two distinct Lamp1 structures at each pole and
soleus myofibers had a more dispersed organization, Lamp1
immunofluorescence was used to determine fiber type in all
future experiments. In young healthy mice, these perinuclear
organelles were similar in size to peripheral Lamp1 positive
structures. However, at 24 months of age, the perinuclear Lamp1
positive structures were markedly enlarged in the EDL fibers
compared to peripheral lysosomes/late endosomes (Figure 1C).
Similarly, in the soleus muscle fibers the Lamp1 positive
structures were also selectively enlarged when compared to
peripheral structures, but they again lacked the perinuclear
organization of the EDL (Figure 1D). We also compared Lamp1
staining in skeletal muscle from a mouse model for Pompe’s
Disease, a glycogen storage disease in which the mice present
with severe muscle loss and weakness. All Lamp1 structures
are significantly enlarged in Pompe’s Disease, but those of
perinuclear localization in both EDL and soleus muscles were
larger than the peripheral structures (Figures 1E,F).
To examine these compartments at the ultrastructural level,
the EDL and soleus muscles from young, aged, and Pompe
mice were fixed, stained, and imaged by transmission electron
microscopy. In young mice, the perinuclear structures in EDL
muscle appeared to be multivesicular in nature and situated at
the polar ends of the nuclei but separated by cytoplasm and
other organelles like mitochondria (Figure 2Aa). Perinuclear
structures were found in the EDL of aged muscle as well and
they also displayed a multivesicular morphology (Figure 2Ab).
The aged perinuclear organelles were also enlarged when
compared to the young muscle fibers. Despite looking at
many ultrathin sections of soleus muscle from young mice,
we were unable to identify any multivesicular structure around
the nuclei (Figure 2Ac). Multiple, small perinuclear organelles
with a random organization were found in aged soleus muscle
and again with a multivesicular appearance (Figure 2Ad). The
same organization pattern was found in Pompe mice, but the
morphology was different. In Pompe EDL, a single large organelle
was found at each end of the myonuclei and they appeared to
be devoid of any ILVs or osmium tetroxide staining. In Pompe
soleus muscle, multiple large organelles were found around
the myonuclei and appeared morphologically similar to the
Pompe EDL perinuclear organelles, although some contained
dark intralumenal material (Figures 2Ae,f).
In skeletal muscle from Pompe mice, these organelles can
reach extremely large sizes but still retain their perinuclear
organization (Figure 2B). The staining pattern of these can
likely be explained by an accumulation of glycogen that does
not stain with osmium tetraoxide. A cropped and enlarged
close up of the aged EDL muscle shows the morphology
of the perinuclear multivesicular structures (Figure 2C). The
structures contain many intraluminal vesicles combined with
a material that stains heavily for osmium tetraoxide (dark
black stain). The average area of these perinuclear structures in
white muscle was measured using ImageJ and the 24 month
aged perinuclear organelles were found to be nearly 4 times
as large as the 2 month organelles (Figure 2D). Individual
muscle fibers from the EDL were also specifically prepared and
embedded for focused ion beam/scanning electron microscopy
(FIB/SEM). A cropped movie of stacked FIB/SEM images shows
the full morphology of one of these perinuclear organelles
(Supplementary Video S1). These structures are bundles of
intraluminal vesicles encapsulated in a membrane. The FIB/SEM
shows there are multiple bundles of vesicles and perhaps even
multiple MVBs that make up the organelle in this perinuclear
location. Again, this organelle is separated from the nucleus by
cytoplasmic material and mitochondria. Together, these images
demonstrate the presence of a unique Lamp1 positive perinuclear
structure in skeletal muscle. These organelles have a fiber
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FIGURE 1 | Individual muscles were digested and myofibers harvested from EDL or soleus were subjected to confocal fluorescent microscopy
with a Lamp1 antibody (red) and Dapi (blue) as described in the Methods Section. Representative images of myofibers from EDL and soleus muscle
isolated from young 2 month old (A,B), aged 24 month old (C,D), and 2 month old Pompe mice (E,F) are shown. Myofibers from the EDL show two distinct
Lamp1 positive structures at each pole of each nucleus whereas these structures are more dispersed and random in myofibers from the soleus muscle. Scale
bar, 10µm.
type specific organization and hypertrophy in muscle wasting
phenotypes such as sarcopenia and Pompe’s Disease.
The Perinuclear Organelles have MVB-Like
Qualities and Store Lipid
Although the TEM images clearly showed the presence
of multivesicular structures, they are highly unusual when
compared to electron microscopy images of other cellular
MVBs. The number and density of the ILVs along with the
quantity of electron dense material suggests that this is a unique
MVB-like compartment. In order to determine if these Lamp1
structures have properties of classic MVBs, we examined the
co-localization of the lysosome/late endosome marker, Lamp1,
with markers for late endosome/MVBs. The cation-independent
mannose-6-phosphate receptor (M6PR) is enriched inMVBs and
lysobisphosphatidic acid (LBPA) is a unique lipid species typically
enriched in MVBs. The perinuclear organelles stained positive
for both markers in young EDL, consistent with these structures
being MVB like (Figures 3A,B, left panels). Since the 488 nm
signal intensity was greater than that of the 594 nm channel,
resulting in a mostly green merged image, the yellow arrows
are aligned between panels to demonstrate the co-localization of
the markers at the perinuclear MVBs. The enlarged perinuclear
structures in aged EDL remained positive for Lamp1 but were
negative for both markers (Figures 3A,B, right panels). The
overall signal intensity of LBPA in aged muscle was lower,
suggesting a general depletion of the unique lipid species.
Interestingly, if a perinuclear MVB remains normal size in
aged muscle, it retains the MVB marker (yellow arrowhead)
suggesting a correlation between the size of the organelle and the
accumulation of these MVB markers. Due to high background
and autofluorescence, immunostaining of Pompe fibers for MVB
markers was inconclusive. Due to this and the fact that the
morphology is strikingly different in the TEM images, it is not
possible to unequivocally identify the structures found in Pompe
myofibers as MVBs.
During aging various lipid and oxidation species have been
shown to accumulate in the perinuclear regions of skeletal and
cardiac muscle (Nakae et al., 2004). Oil red O (ORO) stains
neutral lipids and also fluoresces so it can be used to detect lipids
in conjunction with immunostaining. There is no apparent ORO
staining in the young 2 month old EDL myofibers whereas, ORO
staining co-localizes with Lamp1 in the aged 24 month old EDL
myofibers indicated by arrows (Figure 4). Much like above, the
488 nm signal intensity is stronger than that of the 594 nm signal
and the merged image does not show a yellow merged color.
Cropped and zoomed inserts show the region of interest where
a red dot of ORO is encompassed by a green ring of Lamp1,
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FIGURE 2 | Perinuclear structures have a multi-vesicular body (MVB) like morphology that is enlarged during muscle wasting. Muscle sections from EDL
and soleus were fixed, stained, and imaged with an electron microscope as detailed in the Methods Section. (A) Representative TEM images from young 2 month old,
aged 24 month old, and 2 month old Pompe mice. (B) Low magnification representative image of the Pompe EDL myofiber. (C) Cropped and zoomed image of a
perinuclear MVB from aged 24 month old EDL muscle. The bar in each image indicates the magnification scale size. (D) Quantification of the EDL perinuclear MVB
size from 2 to 24 month old myofibers. The area of the organelle was measured using Image J and the graph represents the average of each group; error bars indicate
SEM, n > 30, *indicates statistical significance as assessed by p < 0.05. The arrow identifies the perinuclear organelle in each image. N, nucleus; S, sarcomere; M,
mitochondria.
showing that the lipid is within these perinuclear structures.
These data suggest that in skeletal muscle, there exists an unusual
perinuclear MVB that hypertrophies and accumulates lipid in
aged muscle.
Perinuclear MVBs Function to Accumulate
and Store Lipofuscin Deposits
Lipofuscin has been well characterized as an oxidized lipid
byproduct that crosslinks and accumulates in postmitotic cells.
To determine whether the perinuclear MVBs contain lipofuscin
we examined lipofuscin autofluorescence (Brunk and Terman,
2002; Feeney et al., 2014). In young, aged, and Pompe EDL
muscle, small puncta were visualized at 488 nm that were
localized to the two perinuclear MVBs in the EDL (Figure 5A).
The images show only faint autofluorescence in EDL muscle
that localizes to the same perinuclear areas as the MVBs. In
young, aged, and Pompe red muscle, autofluorescence was
visualized in and around the myonuclei (Figure 5B). In all mice,
autofluorescence was stronger in the soleus than the EDLmuscle,
with Pompe soleus having a much stronger signal than in aged
wild type mice. The signal is strong enough to bleed into the
405 nm channel, therefore appearing as blue puncta around the
blue Dapi-stained myonuclei (Figure 5B, bottom right panel
insert). Collectively, these data indicate that perinuclear MVBs
accumulate and store lipofuscin deposits in a fiber type-specific
pattern and intensity, which is augmented in diseases of muscle
wasting.
Rapamycin Regulates MVB Size and
Lipofuscin Accumulation
Rapamycin treatment of both aged mice and Pompe mice have
shown marked improvements in muscle mass, strength, and
function (Ashe et al., 2010; Zhang et al., 2014). Young 2 month
and aged 24 month old mice underwent daily intraperitoneal
injections of 4mg/kg of body weight rapamycin for 1 month.
The EDL and soleus muscles were dissected and myofibers
isolated and immunostained. Although rapamycin treatment
had no significant effect on the size or distribution of the
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FIGURE 3 | The perinuclear structures stain for late endosome markers, which are lost upon muscle aging. The EDL muscle was digested and myofibers
were harvested and imaged by confocal fluorescent microscopy as described in the Methods Section. (A) Representative images showing the co-localization of the
mannose-6-phosphate receptor (M6PR) late endosome/MVB marker [green], and the Lamp1 lysosome/late endosome marker [red], in young 2 month old, and aged
24 month old mice. (B) Representative images showing the co-localization of the specific late endosome/MVB marker, lysobisphosphatidic acid (LBPA) [green], and
lysosome/late endosome marker, Lamp1 [red], in young 2 month old and aged 24 month old mice. Dapi (blue) stains the myonuclei in all images. The arrows indicate
the perinuclear MVB at each pole in each image and are aligned between panels to show co-localization. Scale bar, 10µm.
perinuclear MVBs in 2 month old EDL muscle, there was a
significant decrease in the size of the perinuclear MVBs in aged
24 month old EDL muscle. Untreated aged mice showed the
enlarged perinuclear structures with a clear ring of Lamp1 and
rapamycin treatment reduced theseMVBs back to a single puncta
of Lamp1. Using densitometry, the area of these organelles were
measured and rapamycin was found to reduce the size of the
perinuclear MVBs by a little more than half (Figure 6A). This
reduction in size correlated with a restoration of the MVB/late
endosome marker, M6PR, indicated by arrows (Figure 6B).
Despite the reduction in size and restoration of M6PR co-
localization, rapamycin increased the number and intensity of
lipofuscin deposits in EDL muscle as assessed by examining
the autofluorescence at 488 nm (Figure 6C). These lipofuscin
deposits colocalize with the Lamp1 stain, showing they are in the
perinuclear MVBs located at each pole of the EDL myofibers,
indicated by arrows. A similar pattern was also seen in soleus
muscle. Autofluorescent lipofuscin deposits are already more
numerous in red muscle and rapamycin treatment increased
the number and intensity of these lipofuscin deposits, which
were also co-localized with Lamp1 (Figure 6D). Immunoblotting
of tibialis anterior (TA) muscle extracts demonstrated no
statistically significant difference in the amount of Lamp1
protein expressed between young mice (4 months) treated with
and without rapamycin (Figure 6E). Similarly, there was no
difference in Lamp1 levels in aged mice (24 months) treated with
and without rapamycin.
DISCUSSION
Skeletal muscle, like other tissues, has processes in place to
transport substrates around the cell and deliver them to the
necessary organelles. The autophagic and endocytic pathways
are examples of these complicated trafficking processes. The
last step in the endocytic pathway involves the MVB, which
is an organelle that packages substrates in order to deliver
them to the lysosome to be degraded or for secretion via the
exosome pathway (Raposo and Stoorvogel, 2013). The MVB
is morphologically unique due to its ILVs, which sequester
endocytic cargo and are released into the lysosomal lumen
when lysosomes fuse with an MVB. While investigating these
processes in skeletal muscle, unique structures with specific
organizational patterns became apparent and warranted further
investigation.
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FIGURE 4 | The perinuclear MVBs hypertrophy and accumulate lipid in aged muscle. The EDL muscle was digested and myofibers were harvested and
subjected to confocal fluorescent microscopy as described in the Methods Section. The myofibers were stained with Lamp1 (green) for immunofluorescence followed
by staining for oil red O (red). Dapi (blue) stains the myonuclei in all images. Representative images of the co-localization of oil red O fluorescence and the
lysosome/late endosome marker, Lamp1, in young 2 month old and aged 24 month old mice are shown. The arrows indicate the perinuclear MVB at each pole in
each image and are aligned between panels to show co-localization. Inserts in the bottom panel are cropped and zoomed to enable visualization of the red oil red O
puncta inside the ring of Lamp1. Scale bar, 10µm.
White and red muscle fibers have many important differences
like the type of contractile proteins they express, the preferred
nutrient substrates they utilize, and the relative concentration
of organelles like mitochondria (Schiaffino and Reggiani, 2011;
Wang and Pessin, 2013). Many papers have published fiber
type specific effects and these have furthered the divide between
these two types of distinct myofibers. After first analyzing these
perinuclear MVB like structures, there was also a fiber type
specificity in the organizational pattern. EDL muscle contained
two distinct perinuclear MVBs, one at each end of the myonuclei.
Aged soleus muscle contained many perinuclear MVBs that were
randomly distributed near the myonuclei (Figures 1, 2). We
investigated why there might be a fiber type specific pattern by
staining for other organelles and cytoskeletal proteins. There
was no co-localization with any other part of the autophagic
or endocytic pathways and no co-localization with any other
perinuclear organelle like the sarcoplasmic reticulum or Golgi
apparatus. There was no difference in cytoskeletal structure
after looking at microtubules, microfilaments, and intermediate
filaments. The perinuclear structures did co-localize with gamma
tubulin in EDL but not soleus muscle (data not shown). Thus,
for at least EDL muscle, the perinuclear MVBs are located
at the spindle poles of each myonuclei. Why this staining
pattern differs between fiber types is the target of further
investigation.
Sarcopenia is the loss of muscle mass, strength, and function
attributed to aging. Interestingly, the perinuclear MVBs become
enlarged in muscle from aged mice. In 24 month aged mice, the
perinuclear MVBs are selectively enlarged, leaving the peripheral
Lamp1 positive organelles similar in size to young skeletal
muscle. This allows easy identification of this special subset of
MVBs as in EDL muscle, there are two large MVBs flanking
each side of the myonuclei and in soleus muscle there are many
large MVBs around the myonuclei. To examine another muscle
wasting disease, we looked at muscle from the mouse model of
Pompe’s Disease. This glycogen storage disorder causes a great
excess of glycogen to accumulate, especially in the lysosome,
which swells the size of these organelles. As described before,
Lamp1 positive structures in Pompe muscle are greatly enlarged,
yet the perinuclear MVB-like organelles are still the largest
of all the structures. Some of these organelles can reach sizes
equivalent of the myonuclei (Figure 2B). In addition to skeletal
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FIGURE 5 | The perinuclear MVBs contain autofluorescent lipofuscin, which accumulates upon muscle wasting. Individual muscles were digested and
myofibers were harvested from EDL and soleus muscles. Directly after fixing, the fibers were mounted on a coverslip without any immunostaining as described in the
Methods Section. (A) Representative images of myofibers from the EDL muscle at 488 nm (green) in young 2 month old, aged 24 month old, and 2 month old Pompe
mice. (B) Representative images of myofibers from the soleus muscle at 488 nm in young 2 month old, aged 24 month old, and 2 month old Pompe mice. Each
image contains a magnified insert to show autofluorescent material around a myonucleus. The Pompe soleus sample has an additional insert of Dapi only (blue) to
show the autofluorescence is strong enough to bleed into the 405 nm channel. Scale bar, 10µm.
muscle atrophy in aging and Pompe’s disease, there are several
other functional and genetic muscle wasting phenotypes, for
example denervation, disuse atrophy, cancer cachexia, muscular
dystrophy, mTOR deficiency, and Dannon’s disease to name a
few. However, as far as we are aware, the presence of these
unusual MVB like structures in other models of muscle wasting
has yet to be examined.
The perinuclear organelles stain positive for markers of
MVB/late endosomes. However, when they hypertrophy in
muscle wasting phenotypes of aging and Pompe’s disease, they
lose these markers. This appears to be a product of the size
of the organelle and not the age of the muscle, since the few
small perinuclear MVBs in aged muscle remain positive for the
M6PR marker whereas the large MVBs in nearby myonuclei do
not (Figure 3A). This suggests that hypertrophy interferes with
the endocytic trafficking of the M6PR to the enlarged MVB. In
contrast, the hypertrophied perinuclear MVBs stain positive for
ORO, suggesting that lipid can be delivered to the hypertrophied
structures (Figure 4). The failure of MVBs in young wild type
mice to show lipid accumulation could reflect a difference in
delivery, but could also be due to the lack of sensitivity of the
staining in the small organelles.
A particular type of lipid byproduct, lipofuscin, has been
well described as a marker of aging. Lipofuscin is an amalgam
of lipids, carbohydrates, proteins, and metals cross-linked by
aldehydes that form a “plastic” material that cannot be further
digested or undergo exocytosis. Lipofuscin accumulation is
believed to be due to defects in lysosomal degradation (Brunk
and Terman, 2002; Terman and Brunk, 2004). Interestingly,
muscle lipofuscin has been characterized in cardiac muscle as
existing at each pole of the nuclei, but no study has suggested
it is encapsulated in a dynamic organelle (Nakae et al., 2004).
Lipofuscin is detectable in young muscle as small puncta at each
end of the white myonuclei and as randomly distributed puncta
around redmyonuclei, a staining pattern similar to that of Lamp1
and M6PR in these respective muscles. Aged muscle shows a
marked increase in size and number of lipofuscin deposits but
they still have the same organization as the perinuclear MVBs.
Pompe muscle shows an even greater number, size, and intensity
of lipofuscin deposits (Figures 5A,B).
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FIGURE 6 | In vivo rapamycin treatment in aged mice decreases the size of the perinuclear MVBs, restores MVB markers, and increases the number
and intensity of lipofuscin deposits. Aged 24 month old mice were intraperitoneally injected with 4mg/kg rapamycin daily for 1 month. Muscles were then
dissected and individual myofibers harvested from EDL and soleus to be stained for immunofluorescence as described in the Methods Section. (A) Representative
images of EDL myofibers immunostained for Lamp1 (red). The area of the organelle was measured using Image J and the graph represents the average of each
group; error bars indicate SEM, n > 30, *indicates statistical significance as assessed by p < 0.05. (B) Representative images of the co-localization of the M6PR late
endosome/MVB marker [green], and the Lamp1 lysosome/late endosome marker [red], in aged 24 month old EDL muscle. (C) Representative images of EDL
myofibers of autofluorescence at 488 nm (green) and Lamp1 at 594 nm (red). (D) Representative images of soleus myofibers of autofluorescence at 488m and Lamp1
at 594 nm. The arrows indicate the perinuclear MVB at each pole in each image and are aligned between panels to show co-localization. Scale bar, 10µm. (E) Young
mice (4 month) and aged mice (24 month) were treated with and without rapamycin as above for 1 month. The tibialis anterior (TA) was isolated and tissue extracts
were prepared and subjected to immunoblotting with Lamp1 and GAPDH antibodies from three independent mice per condition.
An interesting pattern arises when examining these images.
Red muscle consistently has lipofuscin deposits that are more
intense and numerous. This may result from the large number
of perinuclear MVBs in red muscle compared to the presence
of only two per myonuclei in white muscle. However, the signal
intensity could also be due to the metabolic needs of red muscle.
This type of myofiber prefers oxidative metabolism, and is
therefore using lipids as a nutrient source and creating more lipid
byproducts that can eventually be cross-linked into lipofuscin.
Interestingly, it has been well characterized that white muscle
primarily wastes in both sarcopenia and Pompe’s Disease. Red
muscle is for the most part spared the loss of mass and function.
This suggests that perhaps the number of deposits might not be
important, whereas the size of the MVBs and lipofuscin deposits,
which is greater in white muscle than red, could play a pathologic
role in muscle wasting. Lastly, the TEM and FIB/SEM photos
show dark black stains in the perinuclear MVBs. Lipofuscin has
been shown to be osmiophilic and therefore these dark stains in
the MVBs are likely the lipofuscin deposits (Figure 2C).
Young and aged mice were treated for 1 month with
rapamycin and the perinuclear MVBs were analyzed. Rapamycin
reduced the size of the aged MVBs, restored the M6PR marker,
and increased the number and intensity of autofluorescent
lipofuscin deposits (Figure 6). The first two of these results
are consistent with the general benefits of rapamycin to reduce
aging phenotypes (Harrison et al., 2009; Zhang et al., 2014).
However, the increase in lipofuscin deposits is counterintuitive.
Rapamycin inhibits mTORC1, which phosphorylates and inhibits
transcription factor EB (TFEB). TFEB controls lysosome
biogenesis, so rapamycin turns on TFEB, therefore increasing
all the necessary factors to produce more lysosomes. The
upregulation of lysosomal processes likely leads to the decrease
in MVB size and the restoration of the MVB markers seen
with rapamycin treatment. Interestingly, the smaller MVBs in
muscle from Rapamycin-treated animals had more numerous
and intense lipofuscin deposits. Previous studies have indicated
lipofuscin cannot be degraded or undergo exocytotic trafficking,
so it is possible that a reduction in MVB size leads to a
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concentration of lipofuscin and an increase in its apparent
abundance (Brunk and Terman, 2002; Terman and Brunk, 2004;
Jung et al., 2007). Alternatively, given the increase in M6PR
staining in rapamycin-treated animals, it could reflect increased
trafficking of lipofuscin to these structures. The potential role
of lipofuscin in the pathology of muscle wasting and the
ameliorating effects of rapamycin on sarcopenia will be addressed
in further studies.
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